EO-1022 - Concentra Biosciences
seribantumab (MM-121) - Concentra Biosciences
patritumab deruxtecan (U3-1402) - Daiichi Sankyo, Merck (MSD)
R3Mab - Roche
https://www.abstractsonline.com/pp8/#!/20273/presentation/10071
 
Thomas O'Hare; Jaya Srivastava; Jaclyn Cleveland; Valerie Malyvanh Jansen; David Dornan
 
Mar 26, 2025
 
Prev Next